Scott B. Capps, VP, Clinical Research at CRYOLIFE INC (CRY), sold 14,582 shares at $10.30 ($150K) on 2016-02-19, disclosed to the SEC on 2016-02-23.
Seasonal sale ($150k) by VP, Clinical Research — this insider has traded CRY in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| CRY | SELL | 2019-06-03 | $57K | — | Filing → |
| CRY | SELL | 2018-09-04 | $432K | — | Filing → |
| CRY | SELL | 2017-02-24 | $364K | — | Filing → |